PRNewswire/ - Thryv Therapeutics Inc., a clinical-stage biotechnology company pioneering novel serum glucocorticoid inducible kinase 1 (SGK1) inhibitors for cardiovascular diseases, today announced ...

President Trump received the royal treatment from King Charles on a historic second U.K. state visit, but he's been greeted ...

The market for 100,000-level pure electric SUVs has always been a core area of competition among automakers. Users in this ...

“In the league, we were probably on the wrong side of small margin defeats throughout,” said St Peter’s stalwart Niall McConville. “We were just finding out team, what team starts and what team ...

Innovent to present multiple R&D results of general biomedicine pipeline at the 34th EADV Congress 2025: San Francisco, US Wednesday, September 17, 2025, 18:00 Hrs [IST] Innovent ...

The Real Estate Debt Fund launched March 31, 2025. Institutional shares returned 2.02% during the second quarter, and the ...

Strategic agreement leverages Garmin biometric data for digital health research ...

Half-life of approximately 100 days increases likelihood of once-per-year dosing Pharmacokinetic profile supports the ability to achieve exposures that could lead to higher efficacy and extended off-t ...

Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform technology to build and advance a pipeline of ...

Oruka Therapeutics, Inc. (“Oruka”) (Nasdaq: ORKA), a biotechnology company developing novel biologics designed to set a new standard for the treatment of chronic skin diseases including plaque ...

Cosa Resources Corp. is pleased to announce that project-wide ZTEM surveying at the Astro uranium project has identified over 25 kilometres of prospective east-northeast trending conductive strike ...

With the right approach, teachers can turn a sometimes controversial practice into a helpful tool for inclusion and learning.